Astrana Health [ASTH] vs Brookdale Senior [BKD] Detailed Stock Comparison
Astrana Health
NASDAQ
Loading...
Brookdale Senior
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Astrana Health wins in 12 metrics, Brookdale Senior wins in 7 metrics, with 0 ties. Astrana Health appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Astrana Health | Brookdale Senior | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 55.29 | -9.06 | Brookdale Senior |
| Price-to-Book Ratio | 1.85 | 18.15 | Astrana Health |
| Debt-to-Equity Ratio | 83.20 | 5,198.71 | Astrana Health |
| PEG Ratio | -1.05 | -1.54 | Brookdale Senior |
| EV/EBITDA | 13.24 | 16.07 | Astrana Health |
| Profit Margin (TTM) | 1.04% | -7.95% | Astrana Health |
| Operating Margin (TTM) | 3.11% | 3.34% | Brookdale Senior |
| EBITDA Margin (TTM) | 3.11% | 3.34% | Brookdale Senior |
| Return on Equity | 5.44% | -108.24% | Astrana Health |
| Return on Assets (TTM) | 3.25% | 0.88% | Astrana Health |
| Free Cash Flow (TTM) | $44.17M | $-35.07M | Astrana Health |
| 1-Year Return | -48.66% | 35.70% | Brookdale Senior |
| Price-to-Sales Ratio (TTM) | 0.55 | 0.63 | Astrana Health |
| Enterprise Value | $1.31B | $7.21B | Brookdale Senior |
| EV/Revenue Ratio | 0.54 | 2.36 | Astrana Health |
| Gross Profit Margin (TTM) | 11.91% | 26.56% | Brookdale Senior |
| Revenue per Share (TTM) | $50 | $13 | Astrana Health |
| Earnings per Share (Diluted) | $0.52 | $-1.05 | Astrana Health |
| Beta (Stock Volatility) | 0.81 | 0.90 | Astrana Health |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Astrana Health vs Brookdale Senior Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Astrana Health | 0.42% | -0.38% | -2.17% | 19.54% | -1.43% | -10.34% |
| Brookdale Senior | -0.50% | -2.67% | 3.62% | 19.88% | 43.47% | 58.50% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Astrana Health | -48.66% | -8.35% | 57.93% | 340.76% | 466.08% | 466.08% |
| Brookdale Senior | 35.70% | 79.82% | 175.60% | -65.96% | -51.89% | -68.73% |
News Based Sentiment: Astrana Health vs Brookdale Senior
Astrana Health
News based Sentiment: POSITIVE
Astrana Health reported strong financial performance with significant revenue and EPS growth, coupled with a very positive analyst outlook and a substantial potential upside. This combination of factors makes it a noteworthy development for investors.
Brookdale Senior
News based Sentiment: MIXED
Brookdale experienced a stock rally and positive institutional investment alongside disappointing Q2 financial results and a cautious analyst outlook. The appointment of a new CEO adds another layer to the evolving investment story, making this a significant but complex month for the company.
Performance & Financial Health Analysis: Astrana Health vs Brookdale Senior
| Metric | ASTH | BKD |
|---|---|---|
| Market Information | ||
| Market Cap | $1.39B | $1.94B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 324,610 | 3,273,653 |
| 90 Day Avg. Volume | 348,273 | 2,916,288 |
| Last Close | $28.87 | $8.02 |
| 52 Week Range | $21.20 - $63.20 | $4.45 - $8.66 |
| % from 52W High | -54.32% | -7.39% |
| All-Time High | $133.23 (Nov 15, 2021) | $54.25 (Jun 05, 2006) |
| % from All-Time High | -78.33% | -85.22% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.35% | 0.05% |
| Quarterly Earnings Growth | -0.51% | 0.05% |
| Financial Health | ||
| Profit Margin (TTM) | 0.01% | -0.08% |
| Operating Margin (TTM) | 0.03% | 0.03% |
| Return on Equity (TTM) | 0.05% | -1.08% |
| Debt to Equity (MRQ) | 83.20 | 5,198.71 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $15.58 | $0.44 |
| Cash per Share (MRQ) | $6.85 | $1.06 |
| Operating Cash Flow (TTM) | $130.56M | $218.62M |
| Levered Free Cash Flow (TTM) | $97.63M | $-317,427,360 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | $0.00 |
Valuation & Enterprise Metrics Analysis: Astrana Health vs Brookdale Senior
| Metric | ASTH | BKD |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 55.29 | -9.06 |
| Forward P/E | 18.79 | -13.43 |
| PEG Ratio | -1.05 | -1.54 |
| Price to Sales (TTM) | 0.55 | 0.63 |
| Price to Book (MRQ) | 1.85 | 18.15 |
| Market Capitalization | ||
| Market Capitalization | $1.39B | $1.94B |
| Enterprise Value | $1.31B | $7.21B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.54 | 2.36 |
| Enterprise to EBITDA | 13.24 | 16.07 |
| Risk & Other Metrics | ||
| Beta | 0.81 | 0.90 |
| Book Value per Share (MRQ) | $15.58 | $0.44 |
Financial Statements Comparison: Astrana Health vs Brookdale Senior
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ASTH | BKD |
|---|---|---|
| Revenue/Sales | $654.81M | $812.94M |
| Cost of Goods Sold | $576.84M | $597.02M |
| Gross Profit | $77.97M | $215.92M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $20.34M | $15.44M |
| EBITDA | $31.10M | $113.27M |
| Pre-Tax Income | $16.83M | $-43.31M |
| Income Tax | $6.61M | $-271,000 |
| Net Income (Profit) | $10.22M | $-43.04M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ASTH | BKD |
|---|---|---|
| Cash & Equivalents | $258.52M | $239.73M |
| Total Current Assets | $613.27M | $454.03M |
| Total Current Liabilities | $361.27M | $555.71M |
| Long-Term Debt | $433.40M | $5.43B |
| Total Shareholders Equity | $517.71M | $148.14M |
| Retained Earnings | $292.88M | $-4.10B |
| Property, Plant & Equipment | $47.55M | $2.01B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ASTH | BKD |
|---|---|---|
| Operating Cash Flow | $12.67M | $27.90M |
| Capital Expenditures | $-3.07M | N/A |
| Free Cash Flow | $13.56M | $-18.42M |
| Debt Repayment | $-428.38M | $-70.34M |
| Common Stock Repurchase | $-1.32M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ASTH | BKD |
|---|---|---|
| Shares Short | 1.55M | 12.25M |
| Short Ratio | 4.49 | 4.49 |
| Short % of Float | 0.06% | 0.05% |
| Average Daily Volume (10 Day) | 324,610 | 3,273,653 |
| Average Daily Volume (90 Day) | 348,273 | 2,916,288 |
| Shares Outstanding | 47.93M | 200.02M |
| Float Shares | 37.56M | 233.91M |
| % Held by Insiders | 0.22% | 0.03% |
| % Held by Institutions | 0.53% | 0.99% |
Dividend Analysis & Yield Comparison: Astrana Health vs Brookdale Senior
| Metric | ASTH | BKD |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | $0.00 |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | $0.00 |
| Ex-Dividend Date | N/A | N/A |